AWS
DNA icon

Atria Wealth Solutions’s Ginkgo Bioworks DNA Stock Holding History

Atria Wealth Solutions’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-723
Closed -$9.67K – 1955
2024
Q2 		$9.67K Sell
723
-94
-12% -$2.81K ﹤0.01% 1913
2024
Q1 		$37.9K Sell
817
-37
-4% -$1.92K ﹤0.01% 1930
2023
Q4 		$57.7K Buy
854
+28
+3% +$1.71K ﹤0.01% 1878
2023
Q3 		$59.8K Buy
826
+376
+84% +$30.1K ﹤0.01% 1810
2023
Q2 		$33.5K Buy
450
+100
+29% +$5.92K ﹤0.01% 1829
2023
Q1 		$18.6K Hold
350
– – ﹤0.01% 1838
2022
Q4 		$23.6K Buy
350
+28
+9% +$2.58K ﹤0.01% 1777
2022
Q3 		$40.2K Buy
322
+10
+3% +$1.19K ﹤0.01% 1708
2022
Q2 		$30K Buy
+312
New +$38.1K ﹤0.01% 1603

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return